Condition: Head and Neck Cancer · Locally Advanced Head and Neck Carcinoma · Sponsor: Natalie Lockney
This is a study to establish a safe and feasible dose for prophylactic use of a combination of gabapentin and ketamine in head and neck cancer patients undergoing chemoradiation.
This description comes directly from the study's public registry record.
Vanderbilt-Ingram Service for Timely Access · 800-811-8480 · cip@vumc.org
Always discuss trial participation with your own doctor first.
| Vanderbilt-Ingram Cancer Center | Nashville, Tennessee, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05156060